Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site

Natural killer (NK) cells are a group of innate immune cells that carry out continuous surveillance for the presence of virally infected or cancerous cells. The natural cytotoxicity receptor (NCR) NKp30 is critical for the elimination of a large group of tumor cell types. Although several ligands have been proposed for NKp30, the lack of a conserved structural feature among these ligands and their uncertain physiological relevance has contributed to confusion in the field and hampered a full understanding of the receptor. To gain insights into NKp30 ligand recognition, we have determined the crystal structure of the extracellular domain of human NKp30. The structure displays an I-type Ig-like fold structurally distinct from the other natural cytotoxicity receptors NKp44 and NKp46. Using cytolytic killing assays against a range of tumor cell lines and subsequent peptide epitope mapping of a NKp30 blocking antibody, we have identified a critical ligand binding region on NKp30 involving its F strand. Using different solution binding studies, we show that the N-terminal domain of B7-H6 is sufficient for NKp30 recognition. Mutations on NKp30 further confirm that residues in the vicinity of the F strand, including part of the C strand and the CD loop, affect binding to B7-H6. The structural comparison of NKp30 with CD28 family receptor and ligand complexes also supports the identified ligand binding site. This study provides insights into NKp30 ligand recognition and a framework for a potential family of unidentified ligands.

[1]  Liisa Holm,et al.  Searching protein structure databases with DaliLite v.3 , 2008, Bioinform..

[2]  P. Sun,et al.  Crystal Structure of the Human Natural Killer (NK) Cell Activating Receptor NKp46 Reveals Structural Relationship to Other Leukocyte Receptor Complex Immunoreceptors* , 2003, Journal of Biological Chemistry.

[3]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[4]  V. Streltsov,et al.  Structure of a shark IgNAR antibody variable domain and modeling of an early‐developmental isotype , 2005, Protein science : a publication of the Protein Society.

[5]  Michael Hallek,et al.  Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. , 2007, Immunity.

[6]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[7]  R. Biassoni,et al.  Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells , 1999, The Journal of experimental medicine.

[8]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[9]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[10]  A. Pesce,et al.  Structure of the human NK cell triggering receptor NKp46 ectodomain. , 2003, Biochemical and biophysical research communications.

[11]  P. Sun,et al.  Structural implications of Siglec‐5 mediated sialo‐glycan recognition , 2008, Journal of molecular biology.

[12]  Giovanni Melioli,et al.  Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.

[13]  P. Kremsner,et al.  A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. , 2007, The Journal of infectious diseases.

[14]  A. Porgador,et al.  Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. , 2009, Journal of proteome research.

[15]  A. Fedorov,et al.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.

[16]  K. Yokoyama,et al.  Application of non-radioactive europium (Eu3+) release assay to a measurement of human natural killer activity of healthy and patient populations. , 1996, Immunological investigations.

[17]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[18]  D. F. Barber,et al.  LFA-1 Contributes an Early Signal for NK Cell Cytotoxicity , 2004, The Journal of Immunology.

[19]  P. Sun,et al.  Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Ofer Levi,et al.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus , 2005, Nature Immunology.

[21]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[22]  P. Sun,et al.  Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. , 2001, Immunity.

[23]  D. Margulies,et al.  Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand , 1999, Nature.

[24]  S. Almo,et al.  Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2 , 2008, Proceedings of the National Academy of Sciences.

[25]  M. Bolognesi,et al.  The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. , 2003, Structure.

[26]  Eric O Long,et al.  Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1–HLA-Cw4 complex , 2001, Nature Immunology.

[27]  A. May,et al.  Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 A resolution. , 1998, Molecular cell.

[28]  Yan Zhang,et al.  Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses , 2001, Nature.

[29]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[30]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[31]  Jeffrey C. Boyington,et al.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.

[32]  R. Strong,et al.  Complex structure of the activating immunoreceptor NKG2D and its MHC class I–like ligand MICA , 2001, Nature Immunology.

[33]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[34]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[35]  A. Engert,et al.  Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function , 2008, PloS one.

[36]  D. Y. Lin,et al.  The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors , 2008, Proceedings of the National Academy of Sciences.

[37]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[38]  C Chothia,et al.  Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. , 1994, Journal of molecular biology.

[39]  T. Springer,et al.  A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Eric O Long,et al.  Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors , 1997, Nature.

[41]  Eric Vivier,et al.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans , 2009, The Journal of experimental medicine.

[42]  Fei Long,et al.  BALBES: a molecular-replacement pipeline , 2007, Acta crystallographica. Section D, Biological crystallography.

[43]  Roman A. Laskowski,et al.  PDBsum new things , 2008, Nucleic Acids Res..

[44]  H. M. Geysen,et al.  Strategies for epitope analysis using peptide synthesis. , 1987, Journal of immunological methods.